Iofina plc (FRA:IF7)

Market Cap	124.80M +146.1%
Revenue (ttm)	60.12M +19.1%
Net Income	7.75M +83.7%
EPS	0.04 +79.5%
Shares Out	n/a
PE Ratio	16.10
Forward PE	17.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	0.6250
Previous Close	0.6250
Day's Range	0.6250 - 0.6250
52-Week Range	0.2160 - 0.6650
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 14, 2026

About Iofina

Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, mineral separators, specialty intermediates, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etcha...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2005
• Employees: 126
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IF7

Financial Performance

In 2025, Iofina's revenue was $66.52 million, an increase of 22.12% compared to the previous year's $54.47 million. Earnings were $7.87 million, an increase of 169.64%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 13, 2026

Data Sources Report a data error